Current clinical immunotherapy targets in advanced nonsmall cell lung cancer (NSCLC)

被引：11

作者：

McCarthy, Fiona ^{[1
]}

Roshani, Rozita ^{[1
]}

Steele, Jeremy ^{[2
]}

Hagemann, Thorsten ^{[1
]}

机构：

[1] Univ London, Ctr Canc & Inflammat, Barts Canc Inst, John Vane Sci Ctr, London EC1M 6BQ, England

[2] St Bartholomews Hosp, London, England

来源：

JOURNAL OF LEUKOCYTE BIOLOGY | 2013年 / 94卷 / 06期

关键词：

immunotherapeutic agents; malignancies; tumor; progression-free survival; CD8(+) T-CELLS; PROGNOSTIC-FACTOR; VACCINE; STAGE; MUC1; EXPRESSION; INFILTRATION; ANTIBODY; HETEROGENEITY; CHEMOTHERAPY;

D O I：

10.1189/jlb.0313121

中图分类号：

Q2 [细胞生物学];

学科分类号：

071009 ; 090102 ;

摘要：

Review of current immunotherapeutic approaches in the treatment of non-small cell lung cancer. NSCLC remains one of the most challenging malignancies to treat. Despite the introduction of innovative therapies over the last decade, the 5-year survival of NSCLC is still <20%. Clearly, novel, therapeutic approaches are required. Targeting the immune system to derive meaningful clinical benefit has proved successful in various malignancies in recent years. As a result, there is renewed focus on the use of immunotherapy in lung cancer. In this review, we provide an overview of current immune-modulatory approaches in the treatment of NSCLC.

引用

页码：1201 / 1206

页数：6

共 55 条

[11] A novel cancer vaccine composed of human-recombinant epidermal growth factor linked to a carrier protein: Report of a pilot clinical trial [J].

Gonzalez, G ;

Crombet, T ;

Catala, M ;

Mirabal, V ;

Hernandez, JC ;

Gonzalez, Y ;

Marinello, P ;

Guillen, G ;

Lage, A .

ANNALS OF ONCOLOGY, 1998, 9 (04) :431-435

[12] Beyond the Standard of Care: A Review of Novel Immunotherapy Trials for the Treatment of Lung Cancer [J].

Hall, Richard D. ;

Gray, Jhanelle E. ;

Chiappori, Alberto A. .

CANCER CONTROL, 2013, 20 (01) :22-31

[13] The hallmarks of cancer [J].

Hanahan, D ;

Weinberg, RA .

CELL, 2000, 100 (01) :57-70

[14] Hallmarks of Cancer: The Next Generation [J].

Hanahan, Douglas ;

Weinberg, Robert A. .

CELL, 2011, 144 (05) :646-674

[15] Tumor Cell Expression of Programmed Cell Death-1 Ligand 1 Is a Prognostic Factor for Malignant Melanoma [J].

Hino, Ryosuke ;

Kabashima, Kenji ;

Kato, Yu ;

Yagi, Hiroaki ;

Nakamura, Motonobu ;

Honjo, Tasuku ;

Okazaki, Taku ;

Tokura, Yoshiki .

CANCER, 2010, 116 (07) :1757-1766

[16] Concurrent infiltration by CD8+ T cells and CD4+ T cells is a favourable prognostic factor in non-small-cell lung carcinoma [J].

Hiraoka, K ;

Miyamoto, M ;

Cho, Y ;

Suzuoki, M ;

Oshikiri, T ;

Nakakubo, Y ;

Itoh, T ;

Ohbuchi, T ;

Kondo, S ;

Katoh, H .

BRITISH JOURNAL OF CANCER, 2006, 94 (02) :275-280

[17]

HO SB, 1993, CANCER RES, V53, P641

[18] Involvement of PD-L1 on tumor cells in the escape from host immune system and tumor immunotherapy by PD-L1 blockade [J].

Iwai, Y ;

Ishida, M ;

Tanaka, Y ;

Okazaki, T ;

Honjo, T ;

Minato, N .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (19) :12293-12297

[19] Sipuleucel-T Immunotherapy for Castration-Resistant Prostate Cancer. [J].

Kantoff, Philip W. ;

Higano, Celestia S. ;

Shore, Neal D. ;

Berger, E. Roy ;

Small, Eric J. ;

Penson, David F. ;

Redfern, Charles H. ;

Ferrari, Anna C. ;

Dreicer, Robert ;

Sims, Robert B. ;

Xu, Yi ;

Frohlich, Mark W. ;

Schellhammer, Paul F. ;

Ahmed, T. ;

Amin, A. ;

Arseneau, J. ;

Barth, N. ;

Bernstein, G. ;

Bracken, B. ;

Burch, P. ;

Caggiano, V. ;

Chin, J. ;

Chodak, G. ;

Chu, F. ;

Corman, J. ;

Curti, B. ;

Dawson, N. ;

Deeken, J. F. ;

Dubernet, T. ;

Fishman, M. ;

Flanigan, R. ;

Gailani, F. ;

Garbo, L. ;

Gardner, T. ;

Gelmann, E. ;

George, D. ;

Godfrey, T. ;

Gomella, L. ;

Guerra, M. ;

Hall, S. ;

Hanson, J. ;

Israeli, R. ;

Jancis, E. ;

Jewett, M. A. S. ;

Kassabian, V. ;

Katz, J. ;

Klotz, L. ;

Koeneman, K. ;

Koh, H. ;

Kratzke, R. .

NEW ENGLAND JOURNAL OF MEDICINE, 2010, 363 (05) :411-422

[20] Predominant infiltration of macrophages and CD8+ T cells in cancer nests is a significant predictor of survival in stage IV nonsmall cell lung cancer [J].

Kawai, Osamu ;

Ishii, Genichiro ;

Kubota, Kaoru ;

Murata, Yukinori ;

Naito, Yoichi ;

Mizuno, Tetsuya ;

Aokage, Keiju ;

Saijo, Nagahiro ;

Nishiwaki, Yutaka ;

Gemma, Akihiko ;

Kudoh, Syoji ;

Ochiai, Atsushi .

CANCER, 2008, 113 (06) :1387-1395

← 1 2 3 4 5 6 →